Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Valproic Acid and Breast Cancer: State of the Art in 2021
Anna Wawruszak, Marta Hałasa, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3409-3409
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Epigenetic Regulation in Breast Cancer: Insights on Epidrugs
Ayoung Kim, Kyumin Mo, Hyeonseok Kwon, et al.
Epigenomes (2023) Vol. 7, Iss. 1, pp. 6-6
Open Access | Times Cited: 42
Vorinostat (SAHA) and Breast Cancer: An Overview
Anna Wawruszak, Lidia Borkiewicz, Estera Okoń, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4700-4700
Open Access | Times Cited: 74
Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer
Siddhartha Das Pramanik, Amit Kumar Halder, Ushmita Mukherjee, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 30
Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner
Francesca Giordano, Alessandro Paolì, Martina Forastiero, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 7
Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets
Mengchen Xu, Yiming Hou, Na Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
The role of short-chain fatty acids in cancer prevention and cancer treatment
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 7
Rat Models of Hormone Receptor-Positive Breast Cancer
Raquel Nicotra, Catrin Lutz, Hendrik A. Messal, et al.
Journal of Mammary Gland Biology and Neoplasia (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
Alexander E. Kabakov, Vladimir L. Gabai
Cells (2021) Vol. 10, Iss. 12, pp. 3446-3446
Open Access | Times Cited: 36
Differential molecular mechanistic behavior of HDACs in cancer progression
Tashvinder Singh, Prabhsimran Kaur, Paramdeep Singh, et al.
Medical Oncology (2022) Vol. 39, Iss. 11
Closed Access | Times Cited: 25
The evidence for repurposing anti-epileptic drugs to target cancer
Mir Aroosa, Jonaid Ahmad Malik, Sakeel Ahmed, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 9, pp. 7667-7680
Open Access | Times Cited: 13
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?
Gianfranco Natale, Elisabetta Fini, Pasquale Fabio Calabrò, et al.
Cancer Letters (2023) Vol. 560, pp. 216125-216125
Open Access | Times Cited: 12
Control of Redox Homeostasis by Short-Chain Fatty Acids: Implications for the Prevention and Treatment of Breast Cancer
Carmen González‐Bosch, Patricia A. Zunszain, Giovanni E. Mann
Pathogens (2023) Vol. 12, Iss. 3, pp. 486-486
Open Access | Times Cited: 12
Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa
Alessia Primerano, Emanuela De Domenico, Francesca Cianfarani, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 568-579
Open Access | Times Cited: 4
Epigenetic Modifier Drug Valproic Acid Enhances Cancer Metaphase Chromosome Elasticity and Electron Transport: An Atomic Force Microscopy Approach
Tanya Agrawal, Debashish Paul, Amita Mishra, et al.
JACS Au (2025) Vol. 5, Iss. 2, pp. 766-778
Open Access
Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Repurposing Antiepileptic Drugs for Cancer: A Promising Therapeutic Strategy
Noor Tarawneh, S. A. Hussein, Shtaywy Abdalla
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2673-2673
Open Access
Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
Anna Wawruszak, Jarogniew J. Łuszczki, Arkadiusz Czerwonka, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1211-1211
Open Access | Times Cited: 16
Tetrahydrocurcumin regulates the tumor immune microenvironment to inhibit breast cancer proliferation and metastasis via the CYP1A1/NF-κB signaling pathway
Anqi Zeng, Xinyue Yu, Bao Chen, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin
Avital Granit, Kumudesh Mishra, Dinorah Barasch, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 11
Reliable Identification and Interpretation of Single‐Cell Molecular Heterogeneity and Transcriptional Regulation using Dynamic Ensemble Pruning
Yi Fan, Yunhe Wang, Fuzhou Wang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 6
Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast Cancer
Amal Qattan, Taher Al‐Tweigeri, Kausar Suleman
Biomedicines (2022) Vol. 10, Iss. 2, pp. 366-366
Open Access | Times Cited: 9
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
Avital Granit Mizrahi, Ahinoam Gugenheim, Haneen Hamad, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Epigenetic regulation in epilepsy: A novel mechanism and therapeutic strategy for epilepsy
Shuang Chen, Ming Huang, Da Xu, et al.
Neurochemistry International (2023) Vol. 173, pp. 105657-105657
Closed Access | Times Cited: 5
Deacetylation of Transcription Factors in Carcinogenesis
Marta Hałasa, Kamila Adamczuk, Grzegorz Adamczuk, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11810-11810
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top